Plant molecular farming (PMF) is a game-changer in the world of biomanufacturing, offering a sustainable and scalable solution for producing complex biologics. While it may seem unconventional for companies accustomed to mammalian or microbial systems, recent advancements have transformed plant-based bioproduction into a viable and cost-effective option. One of the key advantages of PMF is its sustainability, as plants grow using low energy inputs rather than energy-intensive systems. This makes it an attractive option for companies looking to reduce their environmental footprint and operating costs. As Marco P.C. Marques, PhD, associate professor at University College London (UCL), points out, "A major advantage is sustainability." This is particularly relevant at a time when regulators and global initiatives are putting pressure on the industry to reduce environmental impact. By leveraging digital sensors and data-driven processors, PMF facilities can tightly monitor and control critical parameters for plant growth, enabling precise, real-time environmental adjustments. This level of control allows producers to select the optimal timing for events such as infiltration and harvest, which is not possible in conventional greenhouses. The long-term goal is to create a semi-continuous, digitally regulated PMF production line that links infiltration, extraction, and purification into a coherent, self-correcting workflow. This would revolutionize the way biologics are produced, making it more efficient and cost-effective. However, there are still challenges to overcome, such as optimizing the process for different plant species and developing more efficient extraction methods. Despite these challenges, PMF has the potential to transform the biomanufacturing industry, offering a sustainable and scalable solution for producing complex biologics. In my opinion, the future of biomanufacturing lies in the hands of PMF, and I am excited to see how this technology continues to evolve and disrupt the industry.